Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

High cost of healthcare is an economic killer

With a large aging population and rising costs, healthcare spending is likely to have negative implications across the economy, according to a recent report from Moody’s.

Thumbnail

Healthcare spending rose 44% over last decade

Healthcare spending has risen rapidly over the last decade, jumping 44 percent per person across all major healthcare categories, according to a new study by the Health Care Cost Institute.

Thumbnail

WSJ: Secret hospital contracts prevent healthcare savings

Healthcare costs continue to balloon in the United States, and secret contracts between hospital systems and insurers may be playing a big role in keeping those costs up.

Thumbnail

Senate approves sweeping opioid bill

The Senate approved a major bill to tackle the opioid crisis with a nearly unanimous vote.

Thumbnail

Coca-Cola considers putting cannabis in a health drink

The Coca-Cola Company admitted it is taking a hard look at the use of cannabis in drinks after reports emerged that the company was in talks to develop a health drink infused with cannabidiol, a compound from the cannabis plant.

New CVS Health policy will exclude drugs above cost-effectiveness threshold

CVS Health will allow self-funded insurers to exclude some drugs from coverage if the cost is too high. The policy has been met with criticism from the pharmaceutical industry, which argues CVS is dividing treatment at arbitrary values.

Thumbnail

$69B CVS-Aetna deal may get regulatory approval soon

CVS Health’s $69 billion takeover of Aetna may soon be greenlit by the U.S. Department of Justice Antitrust Division, according to Reuters, which cited a source familiar with the matter.

Thumbnail

$67B Cigna-Express Scripts deal clears DOJ

The U.S. Department of Justice (DOJ) Antitrust Division has cleared the $67 billion acquisition of Express Scripts by Cigna.

Around the web

The FTC alleges that pharmacy benefit managers have set up a system where they get rich, while patients are forced to pay rising insulin costs. The agency also called out drug manufacturers such as Eli Lilly, Sanofi and Novo Nordisk, saying their own actions have raised serious concerns.

In the post-COVID era, wages for permanent RNs are rising, and wages for travelers are decreasing. A new report tracked these trends and more. 

Two medical device companies have announced a transaction that could shake up the U.S. electrophysiology market. 

Trimed Popup
Trimed Popup